|

EUR/USD: New covid strain is far from being a British problem, euro set dive

EUR/USD has tumbled amid fears of a new coronavirus variant. Fears of the strain's spread in Europe are set to overcome the US stimulus deal and other upbeat developments, Yohay Elam, an Analyst at FXStreet, reports. 

Key quotes

“The new COVID-19 strain that has been identified in the UK is causing panic – most European countries have reacted swiftly with bans on travel to and from the UK. It is likely that the strain is circulating in Europe. Once laboratories identify it elsewhere, it could weigh on the euro as well.”

“The good news for the common currency is that the level of panic may be exaggerated. It is unclear if the new covid strain is the sole culprit of London's quick transmission. Residents in the dense capital are suffering from pandemic fatigue and have been busy doing Christmas shopping.”

“Democrats and Republicans finally struck a fiscal relief deal worth $900 billion. It does include the thorny issues of state aid or liability waivers – nor a last-minute attempt by the GOP to curb the Federal Reserve's lending powers. The move came after a long weekend of talks and is now in the final drafting phase. The upbeat development is liming the market downfall.” 

“There is more room to the downside once the strain of the virus is widespread in the eurozone – but perhaps followed by a more significant recovery later on. In the short run, EUR/USD attempts at recapturing 1.22 look like a ‘dead-cat bounce’ – a small rise followed by another dive.” 

Author

More from FXStreet Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.